Education
About Us
Working with TipRanks
Follow Us
ULTI - ETF AI Analysis
Top Page
REX IncomeMax Option Strategy ETF (ULTI)
Rating:46Neutral
Price Target:
$24.50
Positive Factors
Strong Performing Holdings
Several top holdings, such as IREN and Bloom Energy, have delivered positive year-to-date gains, supporting the fund's performance.
Sector Diversification
The ETF is spread across six sectors, including Technology, Financials, and Industrials, reducing reliance on any single industry.
Focused U.S. Exposure
With over 94% of assets in U.S. companies, the ETF benefits from stability in the world's largest economy.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio, which can eat into investor returns over time.
Underperforming Holdings
Several top positions, such as Upstart Holdings and Sarepta Therapeutics, have posted negative year-to-date returns, dragging down overall performance.
Small Asset Base
With only $5 million in assets under management, the ETF may face liquidity challenges and higher trading costs for investors.
ULTI vs. SPDR S&P 500 ETF (SPY)
AUM6.10M
RegionNorth America
Expense Ratio1.25%
Beta-2.64
IssuerREX Shares
Inception DateOct 31, 2025
Dividend Yield3.83%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume43,659
30 Day Avg. Volume56,826
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
28.93Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering25
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ULTI Summary
The REX IncomeMax Option Strategy ETF (ULTI) is designed for investors who want a mix of income and growth. It focuses on the US total market and includes companies from sectors like technology, financials, and healthcare. Some of its top holdings are Bloom Energy and Sarepta Therapeutics. ULTI generates income through dividends, options trading, and US Treasury investments, making it appealing for those seeking stability and returns. However, it carries risks, such as being heavily influenced by market fluctuations and its reliance on options strategies, which can be complex and volatile.
How much will it cost me?The REX IncomeMax Option Strategy ETF (ULTI) has an expense ratio of 1.25%, meaning you’ll pay $12.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, using strategies like options trading and short-term Treasury investments to enhance returns and generate income.
What would affect this ETF?The ULTI ETF could benefit from positive trends in the technology and financial sectors, which make up a significant portion of its holdings, as well as stable income from US Treasury investments. However, it may face challenges from rising interest rates, which could impact Treasury yields and equity valuations, and sector-specific risks such as regulatory changes in technology or financial markets. Its reliance on options trading adds complexity, which could amplify returns but also increase risk during volatile market conditions.
ULTI Top 10 Holdings
The REX IncomeMax Option Strategy ETF (ULTI) leans heavily on U.S. technology and financial stocks, which together make up over 60% of its portfolio. Rising names like Iris Energy and Bloom Energy are providing a spark, with strong technical trends and growth potential driving performance. However, laggards like Upstart Holdings and Sarepta Therapeutics are holding the fund back, weighed down by bearish trends and profitability concerns. While the fund’s focus on income generation through dividends and options trading adds stability, its concentrated exposure to tech and financials means it’s riding the waves of these sectors’ mixed fortunes.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Bitdeer Technologies | 6.52% | $397.88K | $2.39B | -10.83% | 38 Underperform | |
| Lemonade | 5.01% | $305.87K | $5.03B | 36.67% | 54 Neutral | |
| uniQure | 4.98% | $304.11K | $1.71B | 381.14% | 40 Underperform | |
| Bullish | 4.97% | $302.95K | ― | ― | 43 Neutral | |
| Oscar Health | 4.89% | $298.39K | $3.57B | -15.64% | 45 Neutral | |
| SolarEdge Technologies | 4.83% | $294.50K | $2.06B | 189.98% | 49 Neutral | |
| Galaxy Digital | 4.73% | $288.36K | $9.14B | 38.17% | 70 Outperform | |
| Riot Platforms | 4.71% | $287.55K | $4.73B | 3.25% | 65 Neutral | |
| Kohl's | 4.70% | $286.50K | $1.76B | -7.75% | 68 Neutral | |
| Nano Nuclear Energy Inc. | 4.66% | $284.50K | $1.50B | -11.34% | 35 Underperform |
ULTI Technical Analysis
Negative
―
Price Trends
Market Momentum
15.49
Positive
2.33
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ULTI, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at 15.49 is Positive, neither overbought nor oversold. The STOCH value of 2.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ULTI.
ULTI Peer Comparison
Comparison Results
Performance Comparison
ULTI
REX IncomeMax Option Strategy ETF
16.18
-8.24
-33.74%
BAMD
Brookstone Dividend Stock ETF
―
―
―
YALL
God Bless America ETF
―
―
―
LCAP
Principal Capital Appreciation Select ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
RVER
Trenchless Fund ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents